May 21, 2020
PPD, Inc. Announces Offering of Senior Notes
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that it intends to offer…
Pharmaceuticals, Biotechnology and Life Sciences
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that it intends to offer…
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that it intends to offer…
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that it intends to offer…
Majority of 23 peptide epitopes selected by IMV demonstrated robust antibody responses in an animal model after first and second…
Majority of 23 peptide epitopes selected by IMV demonstrated robust antibody responses in an animal model after first and second…
Majority of 23 peptide epitopes selected by IMV demonstrated robust antibody responses in an animal model after first and second…
Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve…
Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve…
Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve…
Patent allowance follows compelling Phase II data showing Namodenoson resolved all cases of NASH after 12 weeks of treatment, and…